QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Barbara Gillespie
Many of the individual diseases that collectively represent ‘kidney disease’ are themselves rare diseases.
Read More
Peter Rutherford
Kathy Beach
How nurse educators help families address treatment obstacles, driving adherence among patients around the world.
Read More
Eric Hodgins
Science and technology are constantly evolving, enabling researchers to capture more and better data across the drug development lifecycle. But lagging regulations may prevent us from making the most of these new tools.
Read More
Karen Knecht
Helping to move the healthcare system from volume-based to value-based.
Read More
Jon Morris
Amazing innovations amidst the turmoil in Washington make this healthcare IT tech conference one that should not to be missed.
Read More
Ashish Jain
Why biopharma companies are bringing patients into early phase trials, and how they overcome the obstacles.
Read More
The European Medicines Agency clarifies key concepts on orphan drug designation and marketing authorization — which may provide greater predictability for drug developers.
Read More
Avi Kulkarni
Insights from this year’s West Coast Executive Vision Forum program.
Read More